Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and 5-fluorouracil for Recurrent Pterygium
NCT02530801Phase 4Unknown
- Sponsor
- University of Nottingham
- Start
- Jan 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules, Monoclonal Antibodies
01
Overview
A Phase 4 trial of bevacizumab, fluorouracil in pterygium, sponsored by University of Nottingham. Status: unknown.
02
Drugs
bevacizumabfluorouracil
03
Conditions
pterygium
Beyond the preview
Go deeper on NCT02530801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02530801.